404.07
Overview
News
Price History
Option Chain
Financials
Why ELV Down?
Discussions
Forecast
Stock Split
Dividend History
Elevance Health Inc stock is traded at $404.07, with a volume of 1.55M.
It is up +1.23% in the last 24 hours and up +2.74% over the past month.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
See More
Previous Close:
$399.18
Open:
$398.57
24h Volume:
1.55M
Relative Volume:
0.90
Market Cap:
$87.75B
Revenue:
$200.42B
Net Income/Loss:
$5.24B
P/E Ratio:
17.19
EPS:
23.5042
Net Cash Flow:
$6.45B
1W Performance:
-2.76%
1M Performance:
+2.74%
6M Performance:
+12.53%
1Y Performance:
+4.62%
Elevance Health Inc Stock (ELV) Company Profile
Name
Elevance Health Inc
Sector
Industry
Phone
(800) 331-1476
Address
220 VIRGINIA AVENUE, INDIANAPOLIS
Compare ELV vs UNH, CVS, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ELV
Elevance Health Inc
|
404.07 | 87.75B | 200.42B | 5.24B | 6.45B | 23.50 |
|
UNH
Unitedhealth Group Inc
|
408.52 | 371.00B | 449.71B | 12.81B | 19.67B | 13.24 |
|
CVS
Cvs Health Corp
|
101.96 | 130.09B | 407.94B | 2.90B | 7.39B | 2.2771 |
|
CI
Cigna Group
|
298.00 | 78.83B | 278.13B | 6.74B | 7.66B | 23.60 |
|
HUM
Humana Inc
|
379.22 | 45.53B | 137.20B | 1.15B | 1.27B | 9.3439 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-08-26 | Initiated | Evercore ISI | In-line |
| Feb-03-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jan-08-26 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-19-25 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-14-25 | Initiated | Goldman | Neutral |
| Jul-21-25 | Downgrade | Argus | Buy → Hold |
| Jul-18-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Apr-15-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-17-25 | Upgrade | Argus | Hold → Buy |
| Jan-22-25 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-18-24 | Downgrade | Argus | Buy → Hold |
| Jul-18-24 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-24-24 | Initiated | Morgan Stanley | Overweight |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Jul-12-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Apr-27-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-28-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Sep-09-22 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-22-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
View All
Elevance Health Inc Stock (ELV) Latest News
Insider Sell: Dixon Robert L JR Sells Shares of Elevance Health Inc (ELV) - GuruFocus
Form 144: Ronald Penczek sale of 1,531 ELV shares (ELV) - Stock Titan
Elevance Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Elevance Health (ELV) director reports open-market sale of common stock - Stock Titan
[144] Elevance Health, Inc. SEC Filing - Stock Titan
Elevance Health Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Morgan Stanley (MS) issues 300% leveraged PLUS tied to Elevance Health (ELV) stock - Stock Titan
Elevance Health Inc (ELV) Shares Fall 4.7% -- What GF Score of 9 - GuruFocus
Elevance Health Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Elevance Health Inc Stock (ELV) Moved Down by 5.03% on Jun 10: Facts Behind the Movement - TradingKey
Elevance Health (ELV) Reaffirms 2026 Earnings and Expense Guidan - GuruFocus
Elevance Health (ELV) slides as investors refocus on CMS compliance overhang ahead of key late-June deadline - Quiver Quantitative
Elevance Health Inc at Goldman Sachs Healthcare Conference Transcript - GuruFocus
Elevance Health Reaffirms 2026 Adjusted EPS Guidance - marketscreener.com
(ELV) Elevance Health Expects 2026 Adjusted EPS At Least $26.75, vs. FactSet Est of $26.85 - marketscreener.com
[8-K] Elevance Health, Inc. Reports Material Event - Stock Titan
Elevance Health stock: Is ELV underperforming the health care sector? - MSN
Elevance Health Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Elevance files lawsuit against former executive for noncompete violation - The Indiana Lawyer
Morgan Stanley (MS) launches 1‑year 300%‑leveraged PLUS on ELV with $1,370.50 cap - Stock Titan
Elevance Health stock hits 52-week high at 422.65 USD By Investing.com - Investing.com Nigeria
Elevance Health stock hits 52-week high at 422.65 USD - Investing.com
Are Wall Street analysts predicting Elevance stock will climb or sink? - MSN
JPMorgan Adjusts Price Target on Elevance Health to $476 From $411, Maintains Overweight Rating - marketscreener.com
ELV Stock Quote Price and Forecast - CNN
Medicare Advantage in 2026: Enrollment Update and Key Trends - KFF
Q1 Earnings Outperformers: Elevance Health (NYSE:ELV) And The Rest Of The Health Insurance Providers Stocks - Yahoo Finance
UnitedHealth Stock Jumps 20% YTD: Should Investors Jump in Too? - TradingView
Elevance Health Inc (ELV) Stock Price, Trades & News - GuruFocus
How Investors Are Reacting To Elevance Health (ELV) Expanding Digital Access For Underserved Patients - simplywall.st
Elevance Health, Inc. Stock 12‑Month Price Target Raised to $406.38, Implies 4% Upside - TradingView
UnitedHealth Prescribes Another Dividend Increase: Just a Lighter Dose - TradingView
Elevance Health, Inc. Stock 12‑Month Price Target Raised to $405.19, Implies 4% Upside - TradingView
Chutes & Ladders—Ardent Health appoints new CEO; KFF Founding President, CEO to retire - Fierce Healthcare
Elevance Health’s Digital Equity Push Reframes Virtual Care And Investor Narrative - Yahoo Finance
Collis buys Elevance Health (ELV) shares worth $869,519 By Investing.com - Investing.com Nigeria
Elevance Health Inc (ELV) Shares Fall 3.4% -- What GF Score of 8 - GuruFocus
Elevance Health Inc (ELV) Shares Fall 3.4% -- What GF Score of 89 Tells Investors - GuruFocus
Elevance Health Outperforms Sector Market in Early 2026 - asatunews.co.id
Elevance Health Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Collis buys Elevance Health (ELV) shares worth $869,519 - Investing.com
Elevance Health Price Target Raised to $450.00/Share From $375.00 by Truist Securities - Moomoo
Elevance again avoids Medicare Advantage sanctions, but threat remains - Healthcare Dive
Elevance Health: Making The Bull Case For Ongoing Recovery (Rating Upgrade) (NYSE:ELV) - Seeking Alpha
Elevance Health Stock: Is ELV Underperforming the Health Care Sector? - Barchart
Truist Raises Price Target on Elevance Health to $450 From $375, Keeps Buy Rating - Moomoo
Elevance Health, Inc. (ELV) Stock Analysis: Navigating Growth In The Healthcare Sector - DirectorsTalk Interviews
Elevance Health Secures Spot on Evercore Tactical Outperform List - asatunews.co.id
Elevance Health (ELV): One of the Best Undervalued Stocks to Buy According to the Financial Media - Insider Monkey
Elevance Health gains as Medicare sanctions risk abates - MSN
Elevance Health Inc Stock (ELV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):